Media365
The FSSAI has flagged a Nestle product after a sample collected from a hotel in New Delhi was found to be “unsafe” and “substandard” in a laboratory analysis.
The Food Safety and Standards Authority of India (FSSAI) has flagged a Nestle product after a sample collected from a hotel in New Delhi was found to be “unsafe” and “substandard” in a laboratory analysis.
The sample of Nestle’s Low Fat Dairy Whitener was collected from the premises of Bharat Hotels Ltd, which operates The Lalit hotel at Connaught Place in New Delhi.
In a press release, FSSAI said that the Food Analyst’s report found the sample to be non-compliant under the Food Safety and Standards Act, 2006.
The food regulator has now directed the food business operator to immediately stop the sale of the identified product.
Sample collected from The Lalit in Delhi
According to FSSAI, the sample was drawn from the hotel premises and sent for analysis as part of food safety checks. The laboratory report subsequently classified the Nestle Low Fat Dairy Whitener sample as both “unsafe” and “substandard”.
FSSAI said that a copy of the laboratory report was provided to the food business operator for reference and further action. A notice was also issued to Bharat Hotels Ltd regarding the non-compliant product.
According to the release, the company was given an opportunity to appeal against the Food Analyst’s findings within the period prescribed under the FSS Act, 2006.
More from BusinessAt the same time, the food regulator directed the operator to immediately prohibit the sale of the identified product.
FSSAI had earlier acted against Nestle products
The latest action comes after FSSAI had earlier initiated legal proceedings against Nestle India over alleged non-compliance involving infant nutrition products and their promotional material.
The regulator had initiated three separate adjudication cases concerning products including NAN Excella Pro Stage 1 and Lactogen Pro 1. FSSAI had raised objections to claims relating to “5 HMOs” and “Whey Protein” appearing on the products and their promotional material.
The regulator said that such claims were in violation of provisions under the Food Safety and Standards (Foods for Infant Nutrition) Regulations, 2020. It also cited the Infant Milk Substitutes Act, 1992, which restricts advertising and promotion of infant milk substitutes.
Nestle had rejected the allegations and said that its products complied with all applicable regulations. The company had said that the products and their labels had been approved by an FSSAI expert committee and that the claims were factual and supported by scientific literature.
The latest case, however, relates to a different Nestle product and follows a laboratory finding on a sample collected in Delhi.
